Sino Biopharmaceutical (Sino Biopharmaceutical) General and Admin. Expense : $262 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Sino Biopharmaceutical General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Sino Biopharmaceutical's General and Admin. Expense for the six months ended in Dec. 2023 was $114 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $262 Mil.

Sino Biopharmaceutical General and Admin. Expense Historical Data

The historical data trend for Sino Biopharmaceutical's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical General and Admin. Expense Chart

Sino Biopharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

General and Admin. Expense

Get a 7-Day Free Trial

353.23

406.15

343.09

272.45

262.36

Sino Biopharmaceutical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
General and Admin. Expense	Get a 7-Day Free Trial															166.25	176.60	102.85	148.32	113.60

Sino Biopharmaceutical General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $262 Mil.

Sino Biopharmaceutical General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biopharmaceutical (Sino Biopharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (OTCPK:SBHMY) » Definitions » General and Admin. Expense

Comparable Companies

Traded in Other Exchanges

SBMFF:USA 01177:Hong Kong SMZ1:Germany

Address

1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG

Website

https://www.sinobiopharm.com

Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.